Home / Cambrex Waltham (Snapdragon Chemistry) /

Cambrex Waltham (Snapdragon Chemistry)

Our team members with Snapdragon Chemistry Inc., a Cambrex Company, specialize in chemical process development and manufacturing services, leveraging state-of-the-art technology to optimize your process and prepare scaled quantities of your product.

United States North America

Cambrex Waltham (Snapdragon Chemistry)

Our team members with Snapdragon Chemistry Inc., a Cambrex Company, specialize in chemical process development and manufacturing services, leveraging state-of-the-art technology to optimize your process and prepare scaled quantities of your product.

Cambrex Waltham (Snapdragon Chemistry)
Cambrex Waltham (Snapdragon Chemistry)
Cambrex Waltham (Snapdragon Chemistry)
Cambrex Waltham (Snapdragon Chemistry)
Cambrex Waltham (Snapdragon Chemistry)
Cambrex Waltham (Snapdragon Chemistry)
Cambrex Waltham (Snapdragon Chemistry)

About the plant

Our team members with Snapdragon Chemistry Inc., a Cambrex Company, specialize in chemical process development and manufacturing services. We leverage state-of-the-art technology to optimize your process and prepare scaled quantities of your product. Our chemists and engineers work with you to provide reactor design and set-up and portfolio optimization. We also offer comprehensive GMP manufacturing at Waltham with seamless technology transfer and scale-up. 

Facility Details

  • Process development
  • Continuous manufacturing
  • Reactor design and build
  • Portfolio optimization
  • GMP manufacturing

Certifications
  • EMA (EU GMP)
  • FDA (cGMP)
  • Health Canada (Canada GMP)
  • MFDS/KFDA (Republic of Korea GMP)
  • PMDA/MHLW (Japan GMP)
  • MHRA (UK GMP)

Activity
  • CHEMICAL-SYNTHETIC, RSM (Raw Starting Materials), Intermediates, Fine Chemicals, API (Active Pharmaceutical Ingredients), Excipients, Building Blocks manufacturing

Features
  • Uses: Investigational, Commercial (Phase IV), Preclinical, Phase I, Phase II, Phase III, Human
  • Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)
  • DEA: N/A
  • BSL:
  • Therapeutic areas: N/A
  • Markets: FDA (USA), EMA (EU), PMDA (Japan), Health Canada (Canada), MHRA (UK), MFDS (South Korea)

Batch Size / Reactor
  • Small, Medium, 1 - 10 L, 10-100 L, 100 - 1,000 L

Services
  • Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Logistics, Preformulation studies, R&D, Formulation / Galenic design, QbD (Quality by Design), Process development, Process optimization, Process validation, Lyophilization cycle development, Stability studies design, Stability studies execution, ICH Stability studies, Comparability studies, Tech transfer, Pilot plant, Formulation mixing, Lyophilization, Research batches, Engineering batches, Scale-up, Pilot batches, Registration batches, Batch records, Analytical methods development, Analytical methods validation, Release testing of raw materials, Release testing of product, Analytical methods transfer, Batch certification / release, GMP documentation, Storage, Distribution, GDP, Salt screening, Co-crystal screening, Polymorph screening, Crystallization screening, Chiral resolution screening, Milling, Safety studies, Solid form selection, Crystal engineering, PGI assessment (Genotoxic Impurities), Nitrosamine risk assessment, Customized block synthesis, Impurity synthesis

Contact us

If you have any questions or suggestions, click here. We will be happy to assist you.

Want to see all the information?

Unleash the full power of MAI CDMO

Register for free

Liof Pharma
ReigJofre
Pharmaron
Salvat
ChemCon
Shilpa Biologicals